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KESAN-KESAN TINGKAH LAKU DAN AKTIVITI OTAK OLEH 
MITRAGININA DARIPADA MITRAGYNA SPECIOSA KORTH (KRATOM) 
KE ATAS FUNGSI PEMBELAJARAN DAN MEMORI DALAM TIKUS  
 
ABSTRAK 
 Mitraginina, sebatian alkaloid utama daripada Mitragyna speciosa Korth 
telah dikaji secara meluas untuk kesan-kesan farmakologinya. Walau bagaimanapun, 
sedikit maklumat yang diketahui tentang kesannya terhadap fungsi pembelajaran dan 
memori. Dalam penyelidikan ini, kesan-kesan akut mitraginina terhadap peringkat-
peringkat yang berlainan dalam proses pembelajaran dan memori telah dikaji. 
Pemberian pra-latihan, pasca-latihan dan pra-ujian mitraginina (1, 5 dan 10 mg/kg) 
menjejaskan pemerolehan, pengukuhan dan dapatan semula memori dalam prosedur 
penghindaran pasif, ke tahap yang sama seperti morfina. Penyelidikan ini seterusnya 
mengkaji jika kesan mitraginina adalah bergantung kepada prosedur atau secara 
umum ke atas prosedur tingkah laku yang lain. Hasil kajian menunjukkan bahawa 
mitraginina (5 dan 10 mg/kg) menyebabkan defisit pembelajaran spasial dan 
menjejaskan memori rujukan dalam prosedur berselirat air Morris. Kemudian, kesan-
kesan kronik mitraginina (28 hari) ke atas fungsi pembelajaran dan memori dinilai. 
Hasil kajian menunjukkan bahawa kronik mitraginina menjejaskan memori dapatan 
semula prosedur penghindaran pasif semasa penyisihan awal dan ketika abstinens. 
Kesan-kesan mitraginina dinilai lagi menggunakan prosedur pengiktirafan objek 
novel dalam haiwan yang sama. Hasil kajian menunjukkan bahawa haiwan mampu 
mendiskriminasi antara objek novel dan biasa tetapi keupayaan untuk mengingati 
objek yang telah dihadapi sebelum ini telah dilemahkan dalam haiwan yang dirawat 
dengan dos mitraginina yang tinggi (10 mg/kg). Keputusan menunjukkan bahawa 
xxi 
 
dos mitraginina yang tinggi diperlukan untuk mengekalkan kesan-kesan kerosakan 
memori oleh mitraginina dalam tugasan pembelajaran yang baru ketika abstinens. 
Kesan-kesan mitraginina ke atas aktiviti otak dinilai lagi pada haiwan-haiwan yang 
dirawat secara kronik untuk 28 hari. Mitraginina menyebabkan corak EEG yang 
berbeza pada kedua-dua tisu kortikal (frontal dan neokorteks) dan hipokampus. 
Pendedahan berulang kepada dos mitraginina yang sama pada 10 mg/kg 
menyebabkan peningkatan dalam kuasa delta dan penurunan dalam kuasa alfa di 
kedua-dua korteks frontal dan neokorteks. Sebaliknya, pendedahan berulang kepada 
mitraginina menurunkan kuasa delta tanpa mengira dos tetapi hanya mitraginina 
pada 5 dan 10 mg/kg menurunkan kuasa alfa di hipokampus. Perubahan dalam EEG 
ini mencadangkan bahawa mitraginina mampu mencabar kestabilan rangkaian 
kawasan setempat. Di samping itu, pemberian nalokson, antagonis opioid (1.0 
mg/kg) dan bikukulina, antagonis GABAA (0.125 mg/kg) pasca-latihan memulihkan 
memori yang terjejas disebabkan oleh mitraginina, mencadangkan penglibatan sistem 
opioidergik dan GABAergik dalam modulasi kesan-kesan mitraginina ke atas fungsi 
pembelajaran dan memori. Dalam prosedur berselirat air Morris, pemberian agonis 
kolinergik, oksotrimorina (0.1 mg/kg) pasca-latihan, memulihkan defisit 
pembelajaran spasial yang disebabkan oleh mitraginina (5 dan 10 mg/kg). Pemberian 
fisostigmina (0.1 mg/kg), antikolinesterase hanya memulihkan kesan kerosakan oleh 
mitraginina terhadap pembelajaran spasial pada 5 mg/kg tetapi tidak pada dos yang 
lebih tinggi (10 mg/kg). Keputusan ini mungkin menunjukkan bahawa defisit 
pembelajaran spasial yang disebabkan oleh mitraginina adalah berkolerasi dengan 
pengurangan paras asetilkolina di kawasan-kawasan otak yang berkaitan dengan 
memori. Pra-rawatan mitraginina selama 12 hari berturut-turut membawa kepada 
perbezaan aktiviti kolinesterase di dalam otak. Tiada perbezaan dalam aktiviti 
xxii 
 
asetilkolinesterase (AChE) dilihat dalam korteks frontal. Lebihan korteks yang terdiri 
daripada tisu kortikal utama menunjukkan penurunan manakala hipokampus 
menunjukkan peningkatan aktiviti AChE dalam kumpulan yang telah dirawat dengan 
mitraginina pada 10 mg/kg. Secara keseluruhannya, boleh disimpulkan bahawa 
penggunaan mitraginina boleh memberi kesan kepada fungsi pembelajaran dan 
memori seperti yang ditunjukkan oleh prestasi pencapaian tingkah laku yang terjejas 
dan perubahan dalam aktiviti otak. 
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BEHAVIOURAL EFFECTS AND BRAIN ACTIVITY OF MITRAGYNINE 
FROM MITRAGYNA SPECIOSA KORTH (KRATOM) ON LEARNING AND 
MEMORY FUNCTIONS IN RAT 
 
ABSTRACT 
Mitragynine, the major alkaloid from Mitragyna speciosa Korth has been 
widely studied for its pharmacological effects. However, little is known about its 
effects on learning and memory functions. In present study, the acute effects of 
mitragynine on different stages of learning and memory processes were investigated. 
Pre-training, post-training and pre-test administration of mitragynine (1, 5 and 10 
mg/kg) impaired the acquisition, memory consolidation and retrieval of the passive 
avoidance task, to a similar degree as morphine. The study further investigated if the 
effects of mitragynine are either task-dependent or common to other behavioural 
tasks. The results showed that mitragynine (5 and 10 mg/kg) caused spatial learning 
deficits and impaired reference memory in Morris water maze task. Then, chronic 
effects of mitragynine (28 days) on learning and memory functions were assessed. 
Results demonstrated that chronic mitragynine impaired memory retrieval of the 
passive avoidance task during early withdrawal and abstinence. Effects of 
mitragynine were further evaluated using novel object recognition task in the same 
treated-animals. The results indicated that animals were able to discriminate between 
the novel and familiar objects but the ability to remember the previously encountered 
object was attenuated in the animals treated with high dose of mitragynine (10 
mg/kg). The results suggested that high dose of mitragynine is required to maintain 
the memory-impairing effects of mitragynine in a new learning task during 
abstinence. The effects of mitragynine on brain activity were further evaluated in 
xxiv 
 
chronically-treated animals for 28 days. Mitragynine caused dissociative patterns in 
EEG of both cortical tissues (frontal and neocortex) and hippocampus. Repeated 
exposure to equal dose of mitragynine at 10 mg/kg caused an increase in delta power 
and a decrease in alpha power in both frontal cortex and neocortex. On the contrary, 
repeated exposure to mitragynine regardless of the doses decreased the delta power 
but only mitragynine at 5 and 10 mg/kg decreased the alpha power in the 
hippocampus. These changes in EEG may suggest that mitragynine was able to 
challenge the local network stability. In addition, post-training administration of 
naloxone, an opioid antagonist (1.0 mg/kg) and bicuculline, GABAA antagonist 
(0.125 mg/kg) improved memory impairment induced by mitragynine, suggesting the 
participation of the opioidergic and GABAergic systems in modulating the effects of 
mitragynine in learning and memory functions. In Morris water maze task, post-
training administration of cholinergic agonist, oxotremorine (0.1 mg/kg), improved 
the spatial learning deficit induced by mitragynine (5 and 10 mg/kg). The 
administration of physostigmine (0.1 mg/kg), an anticholinesterase only reversed the 
impairing effects of mitragynine on spatial learning at 5 mg /kg but not at higher 
dose (10 mg/kg). These results may indicate that mitragynine-induced spatial 
learning deficit is correlated with the depletion of acetylcholine level in memory-
associated brain regions. Pre-treatment of mitragynine for 12 consecutive days led to 
differential cholinesterase activities in brain. No difference in acetylcholinesterase 
(AChE) activity was observed in frontal cortex. Remaining cortex which consists of 
major cortical tissues showed a decrease whilst hippocampus showed enhanced 
AChE activity in mitragynine-treated group at 10 mg/kg. Taken together, it can be 
concluded that mitragynine consumption can affect learning and memory functions 
as shown by the impaired behavioural performances and changes in brain activity.
1 
 
CHAPTER ONE 
 
INTRODUCTION 
 
1.1 Learning and memory 
Behaviour involves a continuous flow of information between several 
interacting brain systems. The systems process the information and the output 
ultimately controls the behaviour, either directly or indirectly. Under certain 
circumstances, the information being processed may change the neural systems, 
which later alter the processing of similar information in future occasions, and 
eventually change the corresponding output of the system (White and McDonald, 
2002; Shohamy and Adcock; 2010). The changed output causes an alteration in 
behaviour which attributes to a process called „learning‟ and eventually leads to the 
inference of the existence of a „memory‟. 
 
1.1.1 Stages of learning and memory  
„Memory‟ can be defined as the ability to remember previously learned 
information or past experiences (Richter-Levin and Akirav, 2000) and it can be 
measured as a change in behaviour some time after learning (Abel and Lattal, 2001). 
Memory has always been confined to the idea of how new information is stored in 
the brain and how knowledge is organized as a cognitive process (White and 
MacDonald, 2002). Basically, learning and memory processes consist of three 
different phases i.e. memory formation or also known as acquisition, consolidation 
and retrieval or recall of the previously learned information (Izquierdo, 1989; Deiana 
et al., 2011). Acquisition refers to the process on how the new information is 
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encoded whilst the consolidation refers to the state where the newly acquired 
information that is labile and fragile undergoes a lingering process, becoming 
stronger and resilient over time. Retrieval can be defined as a process of recall of the 
stored information (Medina et al., 2008).  
 
 
 
 
 
 
 
 
 
Figure 1.1: The traditional taxonomy of memory systems (Edited from Bird and 
Burgess, 2008). 
 
1.1.2 Types of memory 
Classifications of memories are based on their duration (short- or long-term) 
and their nature which could be archival (short- or long-term memory) or transient 
(working memory) (Deiana et al., 2011; Izquierdo et al., 1999). In mid 1980s, the 
term declarative and „non-declarative‟ were introduced with declarative memory 
refers to one memory system and non-declarative memory refers to other additional 
Memory 
Short-term 
memory 
Long-term 
memory 
Visuospatial 
sketchpad 
 
Phonological 
loop 
 
Neocortical 
sensory and 
motor buffers 
 
Declarative 
Non-
declarative 
Contextual/ 
associative 
Episodic 
Recollection 
Non-
contextual/ 
non-
associative 
Semantic 
Familiarity 
 
Procedural 
memory 
Classical 
conditioning 
Priming 
3 
 
memory systems (Squire, 2004; Figure 1.1). Declarative memory refers to the 
capacity of conscious recollection of facts or events that can be brought to mind and 
described verbally. This kind of memory is often impaired in amnesia and is 
dependent on structures in the medial temporal lobe and midline diencephalon. 
Declarative memory allows the retained information to be compared and contrasted 
and thus, supports the encoding of memories in terms of relationships among 
multiple items and events. In contrast, non-declarative memory can be referred as 
unconscious recollection of experiences such as habits and skills that are expressed 
in performances. This kind of memory occurs due to modifications within 
specialized performance systems and is revealed via reactivation of the systems 
within which the process of learning occurred (Squire, 2004; Deiana et al., 2011).  
Declarative memory can be subdivided into semantic and episodic memory. 
The former constitutes the memory of meanings, facts, understanding and concept-
based knowledge, and the latter implies the ability to re-collect an event in the 
environment in which it originally occurred and involves detailed elements (what), 
location (where) and temporal occurrence (when). Spatial memory is usually 
considered in the context of episodic memory and it implies the ability to attain 
information about one‟s environment and its spatial orientation. Construction of 
cognitive maps is based on the orientation in space as indicated by landmark cues. 
Establishment of these cognitive maps follows either egocentric or allocentric 
strategies. Egocentric involves self-to-object representational system whilst 
allocentric involves relationship of oneself to three-dimensional arrangements of 
objects in the environment (Deiana et al., 2011). 
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McGaugh (1966) has introduced a „three memory trace systems‟ concept 
which consists of immediate memory, short-term memory (STM) and the one that 
consolidates slowly and is relatively permanent (long-term memory, LTM). 
Immediate memory or known as working memory lasts for seconds or a few minutes. 
It depends primarily on the electrical activity of prefrontal cortex cells which are in 
connections with other brain regions. Basically, this type of memory works as an 
online system since it only persists as long as the electrical activity persists 
(Izquierdo et al., 1999). Meanwhile, STM is defined as a memory that develops 
within a few seconds or minutes but lasts for several hours, while LTM has been 
regarded as memory which persists at least for 24 hours. This persistence of LTM 
requires gene activation and protein synthesis which differentiates it from STM. 
Another major difference between the STM and LTM is that the latter is more 
susceptible to extinction (Izquierdo et al., 1999).  
Biochemical investigations led to a finding that showed in CA1 of the 
hippocampus that both STM and LTM are dependent on the integrity of the α-amino-
3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA), N-methyl-D-aspartate 
(NMDA) and metabotropic glutamate receptors as well as their modulation by 
cholinergic muscarinic, β-adrenergic  (stimulant) and GABAA receptors (inhibitory). 
However, only LTM is dependent upon post-training protein kinase C (PKC), protein 
kinase G (PKG) or calcium/calmodulin-dependent protein kinase II (CaMKII) 
activities. Meanwhile, protein kinase A (PKA) shows a distinct influence on each 
STM and LTM whereby, it modulates the STM between zero and 90 minutes after 
training and LTM at zero and after 180 minutes after the training, but not in between 
those two peaks. In LTM, PKA is involved in the phosphorylation of the nuclear 
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transcription factor CREB1 (cAMP response element binding protein) (Izquierdo et 
al, 1999; 2004). 
On the contrary, it seems no involvement of NMDA receptors in the STM 
formation in entorhinal cortex or elsewhere. In addition, the role of PKC and PKA 
are both necessary for the formation of STM and LTM in entorhinal cortex 
(Izquierdo et al., 1999). 
 
1.1.3 Mechanisms of learning and memory 
Learning and memory are basically supported by synaptic plasticity in the 
brain. Synaptic plasticity can be referred as any lasting upregulation or 
downregulation of synaptic strength including long-term potentiation (LTP), long-
term depression (LTD) or depotentiation, and the changes of the synaptic strength 
can occur as a result of certain types of learning (Morgado-Bernal, 2011; Johnston et 
al., 2003; Martin and Morris, 2002). It occurs at the dendritic spines, the major site of 
excitatory synaptic transmission in the vertebrate brain. Studies on the initiation and 
the maintenance of synaptic plasticity, particularly in CA1 pyramidal neurons of the 
hippocampus, have shown that certain types of learning can induce an increase in the 
number or morphological changes of the dendritic spines leading to a new or 
strengthen existing synapses that may form the principle basis of memory (Morgado-
Bernal, 2011; Penzes and Jones, 2008).  
Pharmacological manipulations have succeeded in establishing the major 
molecular mechanisms of memory processes. Initially, activation of relevant 
synapses causes a pre-synaptic release of glutamate which then activates the 
ionotropic AMPA receptors (AMPAr). Activation of this AMPAr leads to an influx 
of Ca
2+ 
into the post-synaptic neuron thus depolarization occurs. Within a few 
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seconds, the local post-synaptic depolarization activates the NMDA receptors 
causing the removal of Mg
+ 
which blocks the channel of NMDA receptors and thus 
giving rise to a massive influx of Ca
2+ 
into the post-synaptic neuron. Consequently, 
CaMKII, PKC and calcineurin are activated. Adenylyl cyclase is also activated by 
the influx of Ca
2+ 
or other modulatory inputs via G-protein-coupled receptors. As a 
result, cyclic adenosine monophosphate (cAMP) level is increased and leads to 
activation of PKA that eventually regulates the synthesis and availability of new 
proteins via activation of CREB in the nucleus (Morgado-Bernal, 2011; Abel and 
Lattal, 2001; Maren and Baudry, 1995; Figure 1.2).  
In this complex process, Ca
2+  
binds to calcium sensor calmodulin (CaM) and 
activates different CaMKs causing morphological changes of the cytoskeleton of the 
neuron, for instance new dendritic spines or persistence enlargement of its head. 
These morphological changes are strongly dependent on the protein synthesis, as 
well as brain derived neurotrophic factor (BDNF) actions (Morgado-Bernal, 2011). 
The formation and the maintenance of new dendritic spines provide a persistent 
structural change upon which a long-term memory is established.  
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Figure 1.2: Molecular events underlie the early and late phases of long-term 
potentiation (Adapted from Abel and Lattal, 2001). 
 
1.1.4 Memory modulatory mechanisms in the brain 
Extensive research has been carried out to investigate the neurobiological 
processes and systems that contribute to the differences in memory strength. 
Modulatory systems not only affect the neurobiological processes of newly acquired 
information but also other mnemonic processes including working memory, memory 
recall and memory extinction (Roozendaal and McGaugh, 2011; Cahill and 
McGaugh, 1996; Figure 1.3). 
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Figure 1.3: Modulatory systems of learning and memory functions in the brain. 
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hyperpolarization and thus reduce the synaptic transmission of dopamine, serotonin 
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receptor has specific sites for benzodiazepines, barbiturates, steroids and ethanol 
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systems. Meanwhile, GABAB is linked to G-proteins and second-messenger system 
that mediates calcium or potassium channels which in turn generating the slow 
inhibitory post-synaptic potentials in several brain regions (Lanctot et al., 2004; 
Staubli et al., 1999). 
Bicuculline, GABAA antagonist has been proven pharmacologically to 
facilitate the memory formation (Izquierdo et al., 1992; Izquierdo and McGaugh, 
2000) while picrotoxin acts by blocking the chloride channel of GABAA receptors, 
facilitates both memory formation and extinction (McGaugh et al., 1990; Izquierdo et 
al., 2004). On the contrary, muscimol (GABAA agonist) that mimics the action of 
GABA disrupts the memory performance and tiagabine, impairs the spatial learning 
via inhibition of the transport of GABA away from the synaptic cleft (Izquierdo et 
al., 2004).  
The importance of GABAergic system is further illustrated in a study using 
PWZ-029, an α5 GABAA selective inverse agonist. It was found that PWZ-029 
administration was able to improve memory in object recognition task after 24-hours 
delay in normal and scopolamine-treated rats. However, PWZ-029 seemed to be 
ineffective to improve the performance in Morris water maze task in either normal or 
scopolamine-treated rats (Milic et al., 2013). 
 
1.1.4(b) Monoaminergic system 
The role of dopaminergic, noradrenergic and serotonergic systems in 
modulating the learning and memory processes in various memory-associated brain 
regions including hippocampus, basolateral amygdala, entorhinal and parietal cortex 
has been well established (Roozendaal and McGaugh, 2011; O‟Carroll et al., 2006; 
Izquierdo and McGaugh; 2000). Pharmacological manipulation has shown that 
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dopamine uptake inhibition improves the acquisition of the inhibitory avoidance and 
increases the hippocampal ACh release (Nail-Boucherie et al., 1998). However, 
studies on dopaminergic modulation on learning and memory showed contrasting 
results which may be due to the activation of different receptor subtypes and 
different experimental design. For instance, activation of D1 receptor caused an 
increase but activation of D2 receptor led to a decrease in the cAMP production. 
Meanwhile, D3 receptor was not related to the adenylate cyclase and was not 
affected by GTP which modulates the binding associated with D1 and D2 receptor 
(Snyder, 1992; Sokoloff et al., 1990; Zarrindast, 2006). Administration of D1 
receptor agonist resulted in enhanced cognitive performance in Morris water maze 
task in rats (Hersi et al., 1995) or had no effects on radial-arm maze learning 
(Wilkerson and Levin, 1999). Findings by Zarrindast et al. (1996) demonstrated that 
administration of low and high doses of apomorphine, a mixed D1/D2 dopamine 
receptor agonist in mice, improved or impaired memory retrieval in the active 
avoidance task, respectively. 
Noradrenergic neurons originated from locus coerulus innervate many brain 
regions, ranging from the spinal cord and cerebellum to the forebrain (Sirvio and 
MacDonald, 1999). The modulatory effects of noradrenergic receptors on learning 
and memory may be mediated via α1-, α2-, β1-, and β2-adrenoceptors (Zarrindast, 
2006). Previous study reported that activation of β-noradrenergic receptor, 3 to 4 
hours after induction can help to maintain LTP in conscious rats (Straube and Frey, 
2003) and thus enhancing the memory. Local infusion of norepinephrine into the 
basolateral amygdala of rats also enhanced the consolidation of two different forms 
of contextual fear conditioning (LaLumiere et al., 2003). In addition, previous study 
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stated the memory-enhancing effects were mediated by the β-adrenoceptors whilst 
α1-adrenoceptors inhibited memory consolidation (Gibbs and Summers, 2001).  
Serotonin (5-hydroxytriptamine, 5-HT) is a biogenic amine that is implicated 
in various physiological functions such as sleep, pain perception, memory and mood 
control (Polter and Li, 2010; Meneses and Perez-Garcia, 2007; Zarrindast, 2006; 
Buhot et al., 2000; McEntee and Crook, 1991). The central nervous system (CNS) 
effects of the serotonin are mediated by 5-HT receptor that can be classified into 
seven main classes; 5-HT1, 5-HT2, 5-HT3, 5-HT4, 5-HT5, 5-HT6 and 5-HT7 which are 
based on structural, transductional and operational features (Hannon and Hoyer, 
2008; Hoyer et al., 2002). Some 5-HT receptors can be further subdivided into 
several subtypes (Zarrindast, 2006). Activation of 5-HT receptors lead to diverse 
effects on learning and memory processes and usually, activation of 5-HT1A 
receptors promote an enhancement in memory consolidation and retrieval (Izquierdo 
et al., 2004). In another study, impairment of short-term memory but not long-term 
memory was observed due to serotonin depletion after intracerebroventricular 
injection of serotonin neurotoxin and serotonin synthesis inhibitor in rats (Hritcu et 
al., 2007). 
A number of studies reported that 5-HT is potentially interacting with other 
neural systems to contribute to a particular function (Lesch and Waider, 2012; 
Ciranna, 2006). In entorhinal cortex, 5-HT activates 5-HT3 receptors on the 
GABAergic neuron causing an inhibition of the cholinergic function (Ramirez et al., 
1996). 5-HT1A antagonist prevents the impairment of spatial learning induced by 
intrahippocampal scopolamine, plausibly via favorable actions on other excitatory 
neurotransmitters (Carli et al., 1995a). In another studies, activation of 5-HT1A 
receptors in the hippocampal CA1 region causes impairment in spatial but not visual 
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discrimination in rats (Carli et al., 1995b) whilst blockade of 5-HT2A receptors in the 
medial prefrontal cortex impairs the recognition memory in spontaneous novelty 
preference task (Bekinschtein et al., 2013).  
Taken together, dopaminergic, noradrenergic and serotonergic play a pivotal 
role in modulating the learning and memory, and it seems possible that these neural 
systems work with other neural systems to modulate the learning and memory 
processes. 
 
1.1.4(c) Cholinergic system 
The involvement of cholinergic system in learning and memory processes has 
gained a great interest among researchers (Blokland, 1996; Robinson et al., 2011; 
Deiana et al., 2011; Miranda et al., 2003) and numerous studies have confirmed the 
participation of cholinergic system in modulating learning and memory processes 
(Easton et al., 2012; Pych et al., 2005; Farr et al., 2000). In rodent, there are at least 
six cholinergic cell groups that project to different brain areas. Both medial septal 
nucleus (Ch1) and vertical (VDBB) limb of the diagonal band of Broca (Ch2) from 
the basal forebrain innervate the hippocampal formation. The horizontal (HDBB) 
limb of the diagonal band of Broca (Ch3) projects to olfactory bulb and thalamic 
reticular region whilst nucleus basalis magnocellularis (NBM, Ch4) issuing fibers to 
the thalamus, cerebral cortex and amygdala. Finally, pedunculopontine (Ch5) and 
laterodorsal tegmentum (Ch6) which are part of the midbrain regions provide 
projections to cortical and various thalamic regions. In addition, there are numerous 
cholinergic fibers that are intrinsic to specific regions, such as striatum (Deiana et al., 
2011; Zarrindast, 2006; Everitt and Robbins, 1997; Figure 1.4). 
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Figure 1.4: Distribution of cholinergic neurons and their projections in the rat brain. 
Abbreviations: MS, medial septum (cell group Ch1); VDBB, vertical limb nucleus of 
the diagonal band Broca (cell group Ch2); HDBB, horizontal limb nucleus of the 
diagonal band Broca (cell group Ch3); NBM, nucleus basalis magnocellularis (cell 
group Ch4); tpp, pedunculopontine tegmental nucleus (cell group Ch5); dltn, 
laterodorsal tegmental nucleus (cell group Ch6); PFC, prefrontal cortex; ICj, islands 
of Calleja; SN, substantia nigra; IP, interpeduncular nucleus; DR, dorsal raphe; LC, 
locus coerulus (Adapted from Everitt and Robbins, 1997).  
 
 ACh is synthesized via the acetylation of choline with acetyl-CoA by enzyme 
choline acetyltransferase (ChAT) in the nerve ending. Accumulation of ACh in the 
synaptic vesicle is driven by proton-pumping ATPase. The quantal release of ACh 
into the synaptic cleft is triggered by depolarization-induced Ca
2+ 
flux. ACh will bind 
to the both pre- and post-synaptic muscarinic (mAChR) and nicotinic (nAChR) 
receptors (Deiana et al., 2011; Taylor and Brown, 1999). Muscarinic receptors are G-
proteins coupled receptors and can be classified into M1, M2, M3, M4 and M5. M1 
receptors are widely distributed in CNS particularly in cerebral cortex, hippocampus 
and amygdala. It is also a dominant mAChR subtype in sympathetic ganglia and 
exocrine glands. M2 receptors are abundant in myocardium and M3 receptors are 
mainly found in smooth muscle and exocrine glands as well as in cortex, 
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hippocampus and thalamus. Meanwhile, M4 receptors showed a scattered appearance 
in cortex and striatum whilst M5 receptors are dense in hippocampus, habenula and 
thalamus (Deiana et al., 2011). 
nAChRs are ligand-gated ion channels with pentameric shape consisting of 
α2-α10, β2-β4, γ, δ and ε (in the adult muscle) subunits that are arranged 
symmetrically around the central pore. Activation of these receptors leads to a rapid 
increase in cellular permeability to Na
+
 and Ca
2+
, depolarization and excitation. α2 is 
scattered in the hippocampus and cortex and α3 is abundant in layer four of cortex, 
dorsal and ventral thalamus including lateral geniculate. α4 can be found mainly in 
cortex, thalamus, amygdala and hippocampus whilst α7 is moderately distributed in 
hippocampus, cortex, cerebellum and brainstem. β2 is dense in thalamus but less in 
cortex and dorsal hippocampus (Deiana et al., 2011). 
Lesions of the cholinergic system or systemic and direct brain injections of 
cholinergic drugs have been used in many studies for its behavioural effects. Local 
administration of muscarinic antagonist, scopolamine into the amygdala interfered 
with the acquisition of the conditioned place preference task (McIntyre et al., 1998). 
In general, many findings have demonstrated that local administration of cholinergic 
agonists and antagonists into the striatum, hippocampus and amygdala, enhanced or 
impaired learning and memory performance in task associated with the neural 
system, respectively (Gold, 2003). 
The availability of the new method called in vivo microdialysis/high 
performance liquid chromatography (HPLC) has enabled the measurement of ACh 
releases (Schlereth et al., 2006; Gold, 2003; McIntyre et al., 2002; Stancampiano et 
al., 1999) from the hippocampus of behaving animals. It has been reported that the 
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increase and decrease in the release of ACh, particularly in hippocampus was 
correlated with the enhancement and impairment of learning and memory (Gold, 
2003). The ACh release may reflect the degree of activation and participation of the 
cholinergic system in the hippocampus in contributing to the performance of the 
learning and memory in a particular task. 
Cholinesterases i.e. acetylcholinesterase and butyrylcholinesterase are pivotal 
enzymes in cholinergic system. Acetylcholinesterase is present in both central 
nervous system and peripheral nervous system such as at the parasympathetic and 
sympathetic ganglia, parasympathetic end-organs, motor end-plates and sweat 
glands. This enzyme primarily functions to hydrolyze the ACh at these junctions and 
eventually terminates the cholinergic transmission (Padilla et al., 1999; Pepeu and 
Giovannini, 2010; Miao et al., 2010). Meanwhile, the role of butyrylcholinesterase is 
an enigma even though reports indicated that this enzyme plays a role during 
developmental processes (Zugno et al., 2013). In contrast to acetylcholinesterase, 
butyrylcholinesterase hydrolyzes both acetylcholine and other esters.  
Acetylcholinesterase activity may be an indicator on how the brain is 
functioning in relation to learning and memory. Isomae et al. (2003) reported that T-
82, a novel acetylcholinesterase inhibitor ameliorated the memory impairment 
induced by acetylcholinergic dysfunction in inhibitory avoidance task. A study found 
an increase in acetylcholinesterase activity in amnesic brain (Biradar et al., 2012), 
but in the imaging study of Alzheimer patients, acetylcholinesterase appeared to be 
reduced in the amygdala (-33%), hippocampus (-14%) and neocortex (-20%) 
(Shinotoh et al., 2003). Therefore, it is possible that consumption of mitragynine may 
also leads to the alteration of the cholinesterase activity in the brain.  
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1.1.4(d) Opioidergic system 
Opioid peptides such as enkephalin and β-endorphin are synthesized and 
released from both peripheral and CNS (Asai et al., 2007; Lin and Pan, 1995; 
Carrasco et al., 1982). Extensive studies have shown that administration of opioid 
peptide agonists and antagonists were able to modulate learning and memory 
processes in a variety of tasks employing both appetitive and aversive motivation, via 
binding to opioid receptors that are widely distributed in the memory-associated 
brain regions.  Opioid agonists act via G-protein coupled opioid receptors known as 
μ-, δ- and κ-receptors (Feng et al., 2012; Al-Hasani and Bruchas, 2011; McDonald, 
2005). Binding to the opioid receptors causes activation of potassium channels, 
inhibition of calcium channels, inhibition of adenylyl cyclase which leads to reduced 
cAMP production as well as inhibition of transmitter release (Dacher and Nugent, 
2011; McDonald, 2005), thus affecting the learning and memory processes. 
Opioid agonists impair memory, but opioid antagonists have memory-
enhancing effects in several paradigms including inhibitory and active avoidance, 
aversively-motivated Y-maze discrimination, and appetitively-motivated spatial 
learning (McGaugh, 1989; Zhu et al., 2011). A recent study reported that 
administration of opioid agonists inhibited the acquisition of passive avoidance task 
at all stages (Zarrindast et al., 2013). However, the inhibitory effects of opioid 
agonist on memory could be reversed by naloxone, an opioid antagonist (Izquierdo, 
1979). Repeated treatment of morphine impaired the acquisition of both simple 
appetitive and cued operant learning but withdrawal for five weeks alleviated the 
impairment. Single morphine exposure caused a disruption in the retrieval of the 
operant memory, but no effect was observed in rats after five-week withdrawal 
(Wang et al., 2006). 
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Opioid agonist may also interact with other neural systems in the brain. It has 
been reported that opioid agonists inhibited noradrenaline release from the 
hippocampus, thus suggesting how it regulates the learning and memory processes 
(Matsumoto et al., 1994). Interaction with the cholinergic system occurs via binding 
to the opioid receptors located on the cholinergic interneurons causing an inhibition 
on the acetylcholine release in the brain, thus contributing to the memory impairment 
(Xi-Geng et al., 2002). It has been reported that administration of opioid agonist, 
morphine into the medial septum causes a reduction in the ACh release in the 
hippocampus (Ragozzino and Gold, 1995). 
 
1.1.4(e) Endocannabinoid system 
Endocannabinoid receptors, particularly cannabinoid receptors type 1 (CB1) 
which are widely distributed in the brain has been shown to be involved in learning 
and memory functions (Moreno and Campolongo, 2014; Peterfi et al., 2012; Castillo 
et al., 2012; Serrano and Parsons, 2011; De Oliveira Alvares et al., 2008). 
Cannabinoids have disruptive effects on the learning and memory processes. This 
was shown through impairment of spatial memory in 8-arm radial maze and 
inhibition of the acquisition and retrieval of passive avoidance task upon 
administration of delta 9-tetrahydrocannabinol, the major psychoactive compound of 
marijuana (Mishima et al., 2001). In another study, spatial learning deficit induced 
by delta 9-tetrahydrocannabinol was blocked by SR241716A, a specific CB1 
antagonist in mice (Da and Takahashi, 2002). Anandamide, the main endogenous 
ligand, impaired memory consolidation of one-trial inhibitory avoidance in mice but 
did not affect the retrieval when given before testing (Costanzi et al., 2003). The 
endocannabinoid system also controls the extinction of the aversive conditioned 
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responses in rat, presumably in the basolateral amygdala (Marsicano et al., 2002). 
The amygdala has been characterized by a great presence of CB1 receptors, which 
are responsible for the local GABAergic transmission (Katona et al., 2001). CB1 
cannabinoid receptors may play a pivotal role in endogenous defense against 
excitotoxicity (Marsicano et al., 2003), in modulation of retrograde signaling in the 
hippocampus (Wilson and Nicoll, 2001) and in LTP induction (Carlson et al., 2002). 
 
1.1.4(f) Histamine 
Emerging evidences have shown that brain histamine plays a role in the 
modulation of memory consolidation via histamine type 1 (H1), type 2 (H2) and type 
3 (H3) receptors (Serafim et al., 2012; Kohler et al., 2011; De Almeida and 
Izquierdo, 1986; 1988). Recent study showed that post-training histamine and 
histamine H3 receptor antagonist thioperamide in the basolateral amygdala enhanced 
and impaired memory consolidation of the step-down inhibitory avoidance task, 
respectively (Benetti and Izquierdo, 2013). On the contrary, another study reported 
that systemic administration of H3 receptor antagonist, thioperamide facilitated 
memory consolidation with no influence on retrieval (Orsetti et al., 2001). In 
addition, a study by Cangioli et al. (2002) has shown that activation of H3 receptors 
by R-α-methyl-histamine in the basolateral amygdala improved the consolidation of 
the fear memory and enhanced the release of ACh.   
 
1.1.4(g) Others 
Glucose has been known to influence memory modulation (Izquierdo et al., 
2004; Smith et al., 2011). Extracellular fluid of glucose in the brain was found to be 
low and even fluctuated across brain areas during spontaneous alternation testing 
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(McNay et al., 2001). In another study, glucose enhanced, and glucose-uptake 
inhibitor 2-deoxyglucose impaired memory consolidation in a day-old chick 
inhibitory avoidance model (Gibbs and Summers, 2002). Systemic or intra-amygdala 
administration of glucose led to the facilitation of the onset of extinction of drug-
induced conditioned reward (Schroeder and Packard, 2003). 
Another factor that may modulate learning and memory is bombesin. It was 
found that intrahippocampal infusion of RC-3095, the bombesin/gastrin-releasing 
peptide antagonist caused an impairment in the inhibitory avoidance in rats, after 
given immediately or two hours after training. This finding may suggest that the 
receptors for bombesin are present in the hippocampus, thus being able to modulate 
the memory consolidation (Roesler et al., 2003). 
 
1.1.5 Memory circuitry in brain: interaction between neural systems 
Based on the lesion of different brain areas, several neural systems have been 
shown to play a significant role in the processing information of different types of 
learning and memory (Gold, 2004; White and McDonald, 2002). Critical interactions 
between these neural systems will determine the time it takes to learn a task, and to 
the extent of the content and the strength of particular memories. Lesion in a 
particular area of the brain leads to a decreased contribution of a neural system to a 
memory processing from its normal proportional participation to a value of zero. 
However, if the brain damage led to enhancement of learning, it could be suggested 
that the neural system that contributes to the efficient learning is „released‟ from its 
competition by a system that contributes to a less efficient learning (Gold, 2004). 
However, the degree of efficiency of the system varies between tasks.  
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As the memory research keeps developing, most of them have been 
concerned with the role of hippocampal formation in the formation and consolidation 
of the explicit memory (Wang and Morris, 2010; Richter-Levin and Akirav, 2000; 
Richter-Levin, 2004; Thierry et al., 2000). The hippocampal formation consists of 
the entorhinal cortex, dentate gyrus, the individual CA fields of the hippocampus 
proper and the subicular complex. Hippocampal formation works together with the 
subcortical and cortical networks where it is believed to store the long-term memory 
(Bird and Burgess, 2008; Wang and Morris, 2010; White and McDonald, 2002; 
Figure 1.5).  
Prefrontal cortex is mainly implicated in the working memory as well as in 
temporal ordering of spatial and non-spatial events and in organization and planning 
of response.  Both hippocampal formation and prefrontal cortex are anatomically and 
functionally associated and due to their reciprocal connections with the temporal and 
parietal association areas of the cerebral cortex, prefrontal cortex may serve as an 
intermediate link between these neocortical areas and the hippocampus (Thierry et 
al., 2000). Direct projection from the hippocampal formation to the prefrontal cortex 
was first described in 1977, in which projections from subiculum to the medial 
frontal cortex were found (Rosene and Van Hoesen, 1977). There were also 
reciprocal connections between caudal portion of the presubiculum and the 
dorsolateral prefrontal cortex (Goldman-Rakic et al., 1984). Direct projections from 
the hippocampal CA1 field to the medial and orbito prefrontal cortex were also 
observed (Barbas and Blatt, 1995). 
Both prefrontal cortex and hippocampus further innervate the ventral 
striatum, particularly the nucleus accumbens which consists of two main regions, the 
„core‟ and the „shell‟. The „core‟ is innervated preferentially by pre-limbic/medial 
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orbito areas of the prefrontal cortex while the „shell‟ is innervated by the 
CA1/subiculum regions of the hippocampus. The nucleus accumbens plays a pivotal 
role in integrating information from the limbic system and cortical regions into goal-
directed behaviours. Nucleus accumbens sends direct projections into several regions 
including pallidum, substantia nigra, hypothalamus and several mesencephalic areas 
(Thierry et al., 2000; Mogenson et al., 1982). 
The amygdala is one of the brain regions that has a significant contribution to 
learning and memory processes. Neurons from the basal nucleus project to the 
entorhinal cortex, CA3 and CA1 fields of the hippocampus, subiculum and 
parasubiculum. These anatomical interactions are believed to be involved in the 
encoding and consolidation (Pare, 2003; McGaugh et al., 1996; Richter-Levin and 
Akirav, 2000), but not in the retrieval or expression of the emotionally based 
experiences, suggesting that amygdala only facilitates memory storage in other brain 
areas (Pare, 2003). It has been shown that amygdala activity modulated the induction 
of the hippocampal LTP (Akirav and Richter-Levin, 1999; 2002). Other than the 
hippocampus, the amygdala also receives extensive projections from cortical areas of 
the temporal lobe, from the substantia nigra, ventral tegmental area, nucleus 
accumbens and from  brain stem areas (White and McDonald, 2002). In general, it 
can be concluded that one or more brain systems can be involved in acquisition, 
consolidation or retrieval processes of one particular types of memory. 
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Figure 1.5: The hippocampus and its connections. a) Hippocampus in the medial 
temporal lobes b) Subcortical connections: red lines; cortical connections: black 
lines; thickness of the black lines approximates to the strength of the connections. 
Abbreviations: MDTN, medial dorsal thalamic nuclei; ATN, anterior thalamic 
nuclei; TE & TEO, inferior temporal areas TE and TEO; LIP, lateral intraparietal 
area; RSp, retrosplenial; Cing gyrus, cingulate gyrus (Adapted from Bird and 
Burgess, 2008).  
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1.2 Electroencephalogram (EEG) 
 
EEG can be referred as amplified electrical activity generated by connecting 
neurons in the brain (Liu et al., 2005; Idris et al., 2014), thus is a reflection of the 
functional connectivity in the brain network. It has been proven to be a very sensitive 
and reliable tool for characterizing drug effects in the CNS (Palenicek et al., 2013; 
Dimpfel, 2005). It can be classified into delta (0.1-4 Hz), theta (4-7 Hz), alpha (7-13 
Hz), beta (13-30 Hz) and gamma (>30 Hz) bands based on range of frequencies 
(Idris et al., 2014). Amplitude of brain waves is measured using microvolt unit (μV). 
Amplitude with less than 20 μV, in between 20-50 μV and more than 50 μV are 
considered as low, medium and high amplitude, respectively (Idris et al., 2014).  
The slow wave delta band (0.1-4 Hz, 20-200 μV) is associated with deep 
sleep and unconsciousness while theta band (4-7 Hz, 20-100 μV) which originated 
from thalamus appears as consciousness slips towards drowsiness. The most 
prominent rhythm in the brain activity is alpha band (7-13 Hz, 20-60 μV), with 
round, sinusoidal or sometimes as sharp wave appearance. Alpha band appears 
mainly in the posterior half of the head, over the parieto-occipital region of the brain. 
This band indicates a relaxed awareness without any attention or concentration. Beta 
band (13-30 Hz, 2-20 μV) which usually found at frontal and central region 
represents the waking rhythm of the brain associated with active thinking or active 
attention. Lastly, the gamma band (> 30 Hz, ~5-10 μV) occurs at certain occasion 
when the sensory stimuli are given. EEG activity originated mainly from pyramidal 
postsynaptic potentials which are in oscillations with several brain regions. The first 
network is with thalamus, thus is referred as thalamocortical networks which is 
modulated by the reticulo-thalamo-cortical circuits. The other network is the extra-
thalamic-cortical circuits which involve the reticular system, hypothalamus, 
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hippocampus, amygdala and basal forebrain nuclei. Finally, the network from the 
other cortex is referred as cortical-cortical networks (Idris et al., 2014). 
EEG characteristics across species are relatively similar (Moretti et al., 2013; 
Sambeth et al., 2007). Changes in EEG characteristics induced by drugs were found 
to be similar in human and rodents (Dimpfel, 2005; van Luijtelaar et al., 2002; 
Dimpfel et al., 1992). These changes are useful in understanding the central activity 
of drugs in human (Sambeth et al., 2007). The electrical power of each frequency 
range changes in parallel with changes in particular behaviour or drug condition 
without affecting the neighbouring frequencies. This notion has been proven true by 
Stahl et al. (1997). Repeated exposure to d-amphetamine produced an increase in the 
alpha activity via activation of the dopamine D2-like receptors, without affecting 
other frequency bands. Finding by Dimpfel and Schober (2001) further supported the 
notion. Administration of α2-adrenoceptor agonist that acts presynaptically led to a 
great increase in electrical theta activity but not other frequencies. However, the 
degree of increment was not similar between brain areas suggesting uneven 
distribution of α2-adrenoceptor in different brain areas.  
Considerable evidences support the role of cholinergic system in modulating 
the brain activity (Dringenberg et al., 2002; Metherate et al., 1992). Blockade of 
stimulation-induced EEG activation by intracortical application of anti-muscarinic 
drugs suggested that acetylcholine promotes activation by a direct effect on cortical 
neurons (Metherate et al., 1992). In another study, cholinergic transmitter was found 
to modulate the changes in electrical delta activity which was intimately linked to 
dopaminergic transmission as shown by the concomitant changes in alpha2 electrical 
power (Dimpfel, 2005). The influence of the dopaminergic system on EEG activity 
was further corroborated via administration of dopamine agonist and antagonist, 
